MX2009005981A - Derivados de quinolina antibacterianos. - Google Patents

Derivados de quinolina antibacterianos.

Info

Publication number
MX2009005981A
MX2009005981A MX2009005981A MX2009005981A MX2009005981A MX 2009005981 A MX2009005981 A MX 2009005981A MX 2009005981 A MX2009005981 A MX 2009005981A MX 2009005981 A MX2009005981 A MX 2009005981A MX 2009005981 A MX2009005981 A MX 2009005981A
Authority
MX
Mexico
Prior art keywords
compounds
quinoline derivatives
pharmaceutically acceptable
treatment
bacterial infection
Prior art date
Application number
MX2009005981A
Other languages
English (en)
Inventor
Koenraad Jozef Lodewijk Marcel Andries
Anil Koul
Jerome Emile Georges Guillemont
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX2009005981A publication Critical patent/MX2009005981A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/08Antibacterial agents for leprosy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con novedosos derivados de quinolina sustituida de acuerdo con la fórmula general (la) o la fórmula (Ib) (Ver fórmulas Ia, Ib) incluyendo cualquier forma estereoquímicamente isomérica de los mismos, un N-óxido de los mismos, una sal aceptable para uso farmacéutico de los mismos o un solvato de los mismos; los compuestos reclamados son útiles para el tratamiento de una infección bacteriana; también se reclama una composición que comprende un vehículo aceptable para uso farmacéutico y, como ingrediente activo, una cantidad terapéuticamente efectiva de los compuestos reclamados, el uso de los compuestos o composiciones reclamados para la elaboración de un medicamento para el tratamiento de una infección bacteriana y un procedimiento para la preparación de los compuestos reclamados.
MX2009005981A 2006-12-06 2007-12-04 Derivados de quinolina antibacterianos. MX2009005981A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125529 2006-12-06
PCT/EP2007/063316 WO2008068270A1 (en) 2006-12-06 2007-12-04 Antibacterial quinoline derivatives

Publications (1)

Publication Number Publication Date
MX2009005981A true MX2009005981A (es) 2009-06-16

Family

ID=38124123

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005981A MX2009005981A (es) 2006-12-06 2007-12-04 Derivados de quinolina antibacterianos.

Country Status (29)

Country Link
US (1) US20110166179A1 (es)
EP (1) EP2099759B1 (es)
JP (1) JP5356246B2 (es)
KR (1) KR101526175B1 (es)
CN (1) CN101553471B (es)
AR (1) AR064152A1 (es)
AT (1) ATE509915T1 (es)
AU (1) AU2007328890B2 (es)
BR (1) BRPI0720133A2 (es)
CA (1) CA2669829C (es)
CL (1) CL2007003517A1 (es)
CY (1) CY1112230T1 (es)
DK (1) DK2099759T3 (es)
ES (1) ES2366062T3 (es)
HK (1) HK1137431A1 (es)
HR (1) HRP20110540T1 (es)
IL (1) IL199084A0 (es)
JO (1) JO2725B1 (es)
ME (1) ME01245B (es)
MX (1) MX2009005981A (es)
NO (1) NO342774B1 (es)
NZ (1) NZ577069A (es)
PL (1) PL2099759T3 (es)
PT (1) PT2099759E (es)
RS (1) RS51848B (es)
RU (1) RU2439058C2 (es)
SI (1) SI2099759T1 (es)
TW (1) TWI487525B (es)
WO (1) WO2008068270A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2522658T1 (sl) * 2010-01-04 2018-12-31 Nippon Soda Co., Ltd. Dušik-vsebujoča heterociklična spojina in kmetijski/hortikulturni germicid
AR086411A1 (es) 2011-05-20 2013-12-11 Nippon Soda Co Compuesto heterociclico conteniendo nitrogeno y fungicida para el uso en agricultura y jardineria
RU2486175C2 (ru) * 2011-09-12 2013-06-27 Закрытое Акционерное Общество "Фарм-Синтез" Производные хинолина, в частности 5,6,7-замещенные 1-(2-хлорхинолин-3-ил)-4-диметиламино-2-(нафталин-1-ил)-1-фенилбутан-2-олы, способ получения и применение соединений
CN104254527B (zh) * 2012-04-27 2017-05-31 詹森药业有限公司 抗菌的喹啉衍生物
AU2013254670B2 (en) * 2012-04-27 2017-03-30 Janssen Pharmaceutica Nv Antibacterial quinoline derivatives
CN106806367A (zh) * 2015-09-29 2017-06-09 王洪燕 一种治疗烧伤后感染的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2301544E (pt) * 2002-07-25 2012-12-10 Janssen Pharmaceutica Nv Novos inibidores de micobactérias
RS51074B (sr) * 2004-01-23 2010-10-31 Janssen Pharmaceutica N.V. Derivati kvinolina i njihova upotreba kao mikobakterijskih inhibitora
DK1753427T3 (da) * 2004-05-28 2008-07-21 Janssen Pharmaceutica Nv Anvendelse af substituerede quinolinderivater til behandling af lægemiddelresistente mykobakteriesygdomme
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis

Also Published As

Publication number Publication date
DK2099759T3 (da) 2011-08-15
NZ577069A (en) 2011-09-30
NO20092547L (no) 2009-08-24
US20110166179A1 (en) 2011-07-07
JO2725B1 (en) 2013-09-15
CY1112230T1 (el) 2015-12-09
IL199084A0 (en) 2010-03-28
CL2007003517A1 (es) 2008-07-11
SI2099759T1 (sl) 2011-09-30
HRP20110540T1 (hr) 2011-08-31
HK1137431A1 (en) 2010-07-30
JP5356246B2 (ja) 2013-12-04
TWI487525B (zh) 2015-06-11
AU2007328890B2 (en) 2013-03-14
CN101553471A (zh) 2009-10-07
ME01245B (me) 2013-06-20
CN101553471B (zh) 2013-04-03
AU2007328890A1 (en) 2008-06-12
RU2009125520A (ru) 2011-01-20
RS51848B (en) 2012-02-29
EP2099759A1 (en) 2009-09-16
EP2099759B1 (en) 2011-05-18
BRPI0720133A2 (pt) 2014-02-04
ATE509915T1 (de) 2011-06-15
AR064152A1 (es) 2009-03-18
KR101526175B1 (ko) 2015-06-05
ES2366062T3 (es) 2011-10-14
WO2008068270A1 (en) 2008-06-12
JP2010511671A (ja) 2010-04-15
CA2669829A1 (en) 2008-06-12
RU2439058C2 (ru) 2012-01-10
TW200845986A (en) 2008-12-01
PL2099759T3 (pl) 2011-09-30
NO342774B1 (no) 2018-08-06
CA2669829C (en) 2016-08-30
PT2099759E (pt) 2011-07-27
KR20090086611A (ko) 2009-08-13

Similar Documents

Publication Publication Date Title
MX2009005978A (es) Derivados de quinolina antibacterianos.
MY145924A (en) Antibacterial quinoline derivatives
HK1137431A1 (en) Antibacterial quinoline derivatives
MX355050B (es) Derivados de quinolina antibacterianos.
MY150411A (en) Antibacterial quinoline derivatives
MX2009005980A (es) Derivados antibacterianos de quinolina.
MY145940A (en) Antibacterial quinoline derivatives
SG166799A1 (en) Quinoline derivatives as antibacterial agents
MX2014013055A (es) Derivados de quinolina antibacterianos.
NZ700507A (en) Pyrimidine derivatives for the treatment of bacterial diseases

Legal Events

Date Code Title Description
FG Grant or registration